Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
EHA 2016
Educating Caregivers and Looking at Patients’ Quality of Life
By
Nikhil Munshi
EHA
,
EHA 2016
Videos
Nikhil Munshi believes caregivers should be informed about the newer medicines so they can be aware of potential side effects as well as medicine's responsibility to take a holistic approach to patients' lives post-treatment.
Read Article
Finding Cost-Effective Ways to Good Outcomes
By
Nikhil Munshi
EHA
,
EHA 2016
Videos
Nikhil Munshi believes caregivers should be informed about the newer medicines so they can be aware of potential side effects as well as medicine's responsibility to take a holistic approach to patients' lives post-treatment.
Read Article
Acalabrutinib, a Second-Generation BTK Inhibitor, Is Active in Previously Untreated CLL
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
ALL – Clinical Oral Presentations: Saturday, June 11
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
ALL – Clinical Poster Session: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Blinatumomab Demonstrates Overall Survival Benefit in Adults with Relapsed ALL in the TOWER Study
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
CD19 CAR T Cells Induce Potent Responses and Control CNS Leukemia in Relapsed ALL
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
CLL – Clinical Poster Session: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Duration of TKI Treatment and Duration of Deep Molecular Response Affect Relapse-Free Survival in CML
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Higher-Dose Daunorubicin Is Effective in Patients with AML Who Harbor FLT3-ITD Mutations
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Page 1 of 3
1
2
3
Top Trending Articles
1.
HOPA Highlights: What's New in 2025?
2.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma